California is joining an exclusive five-state club that gives pharmacists specific prescribing authority. The new status, called "mid-level practitioner,"or MLP, allows California pharmacists to initiate and modify drug therapies that involve controlled substances.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.